Oz Huner

Oz Huner is an experienced healthcare leader with a strong background in product management and strategy, particularly in oncology and clinical genomics. Currently serving as Chief Product Officer at Massive Bio, Oz focuses on developing data-driven products to enhance cancer clinical trials. Previous positions include leading product strategy at Verily Life Sciences and launching the Sema4 Signal portfolio at Sema4. Additional roles include senior director positions at QIAGEN and Genomic Health, where product management and go-to-market strategies were emphasized. Early career experience includes directing clinical bioinformatics at LifeLabs and managing healthcare IT practice at Deloitte, alongside a significant role at the University Health Network in clinical informatics. Oz holds an Honours B.Sc. in Cellular and Molecular Biology from the University of Toronto.